Filed: 11/3/2022ACC: 0001766721-22-000007
📋 What this filing means
AISLING CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 17 equity positions with a total reported market value of $150.6K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
17
Positions
$150.6K
Total AUM (reported)
26.54M
Total Shares
Allocation by class
COM$130.7K86.8%
SPONSORED ADS$13.6K9.0%
COM CL A$5.7K3.8%
CL A COM$609.000.4%
Portfolio Concentration
Top 3$98.6K65.5%
4–10$45.4K30.1%
11–25$6.7K4.4%
Top 3 weight
65.5%
Top 10 weight
95.6%
Voting Authority Distribution
Total shares with voting rights: 26.54M
Sole
Full voting authority
26.54M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole17
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings17
Rows:
BridgeBio Pharma Inc. (BBIO)
SOLEShares6.07M
TypeSH
Market value$60.3K
40.05%
Sole
6.07M
Shared
0.00
None
0.00
Syndax Pharmaceuticals, Inc. (SNDX)
SOLEShares1.02M
TypeSH
Market value$24.6K
16.36%
Sole
1.02M
Shared
0.00
None
0.00
Verona Pharma plc (VRNA)
SOLEShares1.33M
TypeSH
Market value$13.6K
9.04%
Sole
1.33M
Shared
0.00
None
0.00
Monte Rosa Therapeutics Inc. (GLUE)
SOLEShares1.47M
TypeSH
Market value$12.0K
7.99%
Sole
1.47M
Shared
0.00
None
0.00
Aclaris Theraputics Inc. (ACRS)
SOLEShares634.46K
TypeSH
Market value$10.0K
6.63%
Sole
634.46K
Shared
0.00
None
0.00
Biomea Fusion Inc. (BMEA)
SOLEShares798.76K
TypeSH
Market value$7.8K
5.19%
Sole
798.76K
Shared
0.00
None
0.00
Nuvation Bio Inc. (NUVB)
SOLEShares2.54M
TypeSH
Market value$5.7K
3.78%
Sole
2.54M
Shared
0.00
None
0.00
Poseida Therapeutics Inc. (PSTX)
SOLEShares1.04M
TypeSH
Market value$3.7K
2.45%
Sole
1.04M
Shared
0.00
None
0.00
Elevation Oncology Inc. (ELEV)
SOLEShares2.83M
TypeSH
Market value$3.2K
2.13%
Sole
2.83M
Shared
0.00
None
0.00
Reneo Pharmaceuticals Inc. (RPHM)
SOLEShares886.08K
TypeSH
Market value$3.0K
1.97%
Sole
886.08K
Shared
0.00
None
0.00
Spruce Biosciences, Inc. (SPRB)
SOLEShares1.21M
TypeSH
Market value$1.7K
1.10%
Sole
1.21M
Shared
0.00
None
0.00
Viracta Therapeutics Inc. (VIRX)
SOLEShares288.57K
TypeSH
Market value$1.2K
0.82%
Sole
288.57K
Shared
0.00
None
0.00
Marker Therapeutics, Inc. (MRKR)
SOLEShares3.14M
TypeSH
Market value$1.2K
0.77%
Sole
3.14M
Shared
0.00
None
0.00
Aeglea Biotherapeutics Inc. (AGLE)
SOLEShares1.69M
TypeSH
Market value$890.00
0.59%
Sole
1.69M
Shared
0.00
None
0.00
AVROBIO, Inc. (AVRO)
SOLEShares1.01M
TypeSH
Market value$646.00
0.43%
Sole
1.01M
Shared
0.00
None
0.00
Atreca Inc. (BCEL)
SOLEShares387.65K
TypeSH
Market value$609.00
0.40%
Sole
387.65K
Shared
0.00
None
0.00
Talaris Therapeutics Inc. (TALS)
SOLEShares175K
TypeSH
Market value$460.00
0.31%
Sole
175K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BridgeBio Pharma Inc. (BBIO)SOLE | COM | 6.07M | SH | $60.3K 40.05% | 6.07M | 0.00 | 0.00 |
Syndax Pharmaceuticals, Inc. (SNDX)SOLE | COM | 1.02M | SH | $24.6K 16.36% | 1.02M | 0.00 | 0.00 |
Verona Pharma plc (VRNA)SOLE | SPONSORED ADS | 1.33M | SH | $13.6K 9.04% | 1.33M | 0.00 | 0.00 |
Monte Rosa Therapeutics Inc. (GLUE)SOLE | COM | 1.47M | SH | $12.0K 7.99% | 1.47M | 0.00 | 0.00 |
Aclaris Theraputics Inc. (ACRS)SOLE | COM | 634.46K | SH | $10.0K 6.63% | 634.46K | 0.00 | 0.00 |
Biomea Fusion Inc. (BMEA)SOLE | COM | 798.76K | SH | $7.8K 5.19% | 798.76K | 0.00 | 0.00 |
Nuvation Bio Inc. (NUVB)SOLE | COM CL A | 2.54M | SH | $5.7K 3.78% | 2.54M | 0.00 | 0.00 |
Poseida Therapeutics Inc. (PSTX)SOLE | COM | 1.04M | SH | $3.7K 2.45% | 1.04M | 0.00 | 0.00 |
Elevation Oncology Inc. (ELEV)SOLE | COM | 2.83M | SH | $3.2K 2.13% | 2.83M | 0.00 | 0.00 |
Reneo Pharmaceuticals Inc. (RPHM)SOLE | COM | 886.08K | SH | $3.0K 1.97% | 886.08K | 0.00 | 0.00 |
Spruce Biosciences, Inc. (SPRB)SOLE | COM | 1.21M | SH | $1.7K 1.10% | 1.21M | 0.00 | 0.00 |
Viracta Therapeutics Inc. (VIRX)SOLE | COM | 288.57K | SH | $1.2K 0.82% | 288.57K | 0.00 | 0.00 |
Marker Therapeutics, Inc. (MRKR)SOLE | COM | 3.14M | SH | $1.2K 0.77% | 3.14M | 0.00 | 0.00 |
Aeglea Biotherapeutics Inc. (AGLE)SOLE | COM | 1.69M | SH | $890.00 0.59% | 1.69M | 0.00 | 0.00 |
AVROBIO, Inc. (AVRO)SOLE | COM | 1.01M | SH | $646.00 0.43% | 1.01M | 0.00 | 0.00 |
Atreca Inc. (BCEL)SOLE | CL A COM | 387.65K | SH | $609.00 0.40% | 387.65K | 0.00 | 0.00 |
Talaris Therapeutics Inc. (TALS)SOLE | COM | 175K | SH | $460.00 0.31% | 175K | 0.00 | 0.00 |